Literature DB >> 16702197

Anti-RANKL therapy--implications for the bone-vascular-axis in CKD? Denosumab in post-menopausal women with low bone mineral density.

Ralf Westenfeld1, Markus Ketteler, Vincent M Brandenburg.   

Abstract

Entities:  

Year:  2006        PMID： 16702197     DOI： 10.1093/ndt/gfl245

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  2 in total

1.  Safety and efficacy of denosumab in osteoporotic hemodialysed patients.

Authors:  Francescaromana Festuccia; Maryam Tayefeh Jafari; Alessandra Moioli; Claudia Fofi; Simona Barberi; Stefano Amendola; Salvatore Sciacchitano; Giorgio Punzo; Paolo Menè
Journal:  J Nephrol       Date:  2016-07-09       Impact factor: 3.902

2.  Severe Hypophosphatemia Following Denosumab Administration in a Hemodialysis Patient with Progressive Prostate Cancer.

Authors:  Hiroshi Masuda; Kanya Kaga; Masahiko Inahara; Kazuhiro Araki; Satoko Kojima; Yukio Naya; Makoto Takano
Journal:  Urol Case Rep       Date:  2017-04-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.